Self-Measured Waist Circumference Often Falls Short

This article originally appeared here.
Share this content:
Self-Measured Waist Circumference Often Falls Short
Self-Measured Waist Circumference Often Falls Short

THURSDAY, May 19, 2016 (HealthDay News) -- Self-measured waist circumference has a clinically important false-negative rate compared with professionally-measured waist circumference, according to a study published in the May/June issue of the Annals of Family Medicine.

Barbara G. Carranza Leon, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues investigated whether self-measured waist circumference is sufficiently accurate to replace professionally-measured waist circumference. Waist circumference was self-measured at the same visit during which a professionally-measured waist circumference was obtained among 585 women and 165 men.

The researchers observed no significant difference in self- and professionally-measured waist circumference but there was a clinically important false-negative rate for the self-measurements. Based on professionally-measured waist circumference, 11 and 52 percent of normal weight and overweight women, respectively, were in a high-risk category for metabolic syndrome; 57 and 18 percent of these women, respectively, undermeasured their own waist circumference and fell below the cut-off. Among men, 15 and 84 percent of overweight and class I obese, respectively, had a professionally-measured waist circumference putting them in the high-risk category; 23 and 16 percent, respectively, undermeasured their waist circumference.

"Despite standardized pictorial instructions for self-measured waist circumference, the false-negative rate of self-measurements approached or exceeded 20 percent for some groups at high risk for poor health outcomes," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Artificial Intelligence Promising for CA, Retinopathy Diagnoses

Artificial Intelligence Promising for CA, Retinopathy Diagnoses

Two studies evaluate use; one for breast cancer, the other for diabetic retinopathy

USPSTF Recommends Against Hormone Tx Post Menopause

USPSTF Recommends Against Hormone Tx Post Menopause

Benefits do not outweigh harms of using hormone therapy for prevention of chronic conditions

Omalizumab Ups Efficacy of Multifood Oral Immunotherapy

Omalizumab Ups Efficacy of Multifood Oral Immunotherapy

Findings in multifood allergic pediatric patients

is free, fast, and customized just for you!

Already a member?

Sign In Now »